ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
21.84
-0.49 (-2.19%)
Apr 25, 2025, 12:30 PM EDT - Market open

ADMA Biologics Market Cap

ADMA Biologics has a market cap or net worth of $5.19 billion as of April 25, 2025. Its market cap has increased by 265.59% in one year.

Market Cap
5.19B
Enterprise Value
5.28B
1-Year Change
265.59%
Ranking
Category
Stock Price
$21.84

Market Cap Chart

Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $5.19B, an increase of 10,237.68%. That is a compound annual growth rate of 49.56%.

History

DateMarket Cap% Change
Apr 23, 20255.16B27.36%
Dec 31, 20244.05B296.92%
Dec 29, 20231.02B33.78%
Dec 30, 2022763.50M176.53%
Dec 31, 2021276.10M49.73%
Dec 31, 2020184.40M-22.29%
Dec 31, 2019237.30M114.17%
Dec 31, 2018110.80M-12.41%
Dec 29, 2017126.50M91.67%
Dec 30, 201666.00M-23.70%
Dec 31, 201586.50M-16.67%
Dec 31, 2014103.80M44.37%
Dec 31, 201371.90M43.23%
View and export this data all the way back to 2013. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 754.80B
UnitedHealth Group 388.03B
Johnson & Johnson 370.42B
AbbVie 314.26B
Novo Nordisk 276.62B
Abbott Laboratories 222.57B
AstraZeneca 213.42B
Novartis AG 208.99B
Market Cap Rankings